Babs G. Taal

Cancer Genomics Centre — Netherlands

Medicine · Health Sciences

49h-index9.4kcitations148works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroendocrine Tumor Research Advances(46), Neuroblastoma Research and Treatments(34), Lung Cancer Research Studies(24), Gastric Cancer Management and Outcomes(22), Genetic factors in colorectal cancer(18)

Publications147 total

ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms
Neuroendocrinology·2016· 325 cited
ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
Neuroendocrinology·2016· 484 citedOpen Access
Neuroendocrine Tumors of the Lung: A Comprehensive Overview
International Journal of Endocrine Oncology·2014· 1 cited
How to Elicit Many Probabilities
arXiv (Cornell University)·2013· 100 citedOpen Access
Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: Experience of two decades of cancer registry
European Journal of Cancer·2013· 248 cited
Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours
British Journal of Cancer·2013· 114 citedOpen Access
Front & Back Matter
Neuroendocrinology·2012
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors
Neuroendocrinology·2012· 521 cited
Author Index Vol. 95, No. 2
Neuroendocrinology·2012Open Access
Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours
British Journal of Cancer·2011· 46 citedOpen Access
Expression and ligand binding of bombesin receptors in pulmonary and intestinal carcinoids.
PubMed·2011· 9 cited
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments
European Journal of Cancer·2011· 119 citedOpen Access
Somatostatin receptor scintigraphy and chromogranin A assay in staging and follow-up of patients with well-differentiated neuroendocrine tumors
Nuclear Medicine Communications·2011· 10 cited
An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival
Annals of Oncology·2011· 35 citedOpen Access
Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours
Tumor Biology·2011· 13 cited
Implementation of endoscopic ultrasound for lung cancer staging
Gastrointestinal Endoscopy·2009· 45 cited
Chromogranin-A and N-Terminal Pro-Brain Natriuretic Peptide: An Excellent Pair of Biomarkers for Diagnostics in Patients With Neuroendocrine Tumor
Journal of Clinical Oncology·2009· 120 citedOpen Access
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biotherapy
Neuroendocrinology·2008· 72 cited
Chromogranin A as an Alternative to 5-Hydroxyindoleacetic Acid in the Evaluation of Symptoms during Treatment of Patients with Neuroendocrine Tumors
Neuroendocrinology·2008· 58 cited
Biomarkers in management of carcinoid tumours
Biomedicine & Pharmacotherapy·2008
page 1 of 8Next →

Frequent Co-authors

Henk Boot(11), Hans F. A. Vasen(9), Fred H. Menko(9), Daphne de Jong(6), Fokko M. Nagengast(6), Jan H. Kleibeuker(6), Catharina M. Korse(5), P. van Heerde(5), Dermot O’Toole(4), John Ramage(4), Gerrit Griffioen(4), G Griffioen(4), P. Meera Khan(4), F.C.A. den Hartog Jager(4), Johannes M.G. Bonfrèr(4), Massimo Falconi(3), José Manuel Lopes(3), Diego Ferone(3), Neil K. Aaronson(3), Otto Visser(3)